CoChat

Modelling primaquine-induced haemolysis in G6PD deficiency

Watson, James, Taylor, Walter RJ, Menard, Didier, Kheng, Sim, White, Nicholas J · 2017 · eLife
Cited by 59

The DOI matches its Crossref record.

Abstract

Primaquine is the only drug available to prevent relapse in vivax malaria. The main adverse effect of primaquine is erythrocyte age and dose-dependent acute haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd). As testing for G6PDd is often unavailable, this limits the use of primaquine for radical cure. A compartmental model of the dynamics of red blood cell production and destruction was designed to characterise primaquine-induced haemolysis using a holistic Bayesian analysis of all published data and was used to predict a safer alternative to the currently recommended once weekly 0.75 mg/kg regimen for G6PDd. The model suggests that a step-wise increase in daily administered primaquine dose would be relatively safe in G6PDd. If this is confirmed, then were this regimen to be recommended for radical cure patients would not require testing for G6PDd in areas where G6PDd Viangchan or milder variants are prevalent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.23061

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 29

  1. Alving, 1960, Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the chesson strain of piasmodium vivax by intermittent regimens of drug administration: a preliminary report, Bulletin of the World Health Organization, 22, 621
  2. Beck, 2016, Estimation of the antirelapse efficacy of tafenoquine, using Plasmodium vivax Genotyping, Journal of Infectious Diseases, 213, 794, 10.1093/infdis/jiv508 · DOI
  3. Beutler, 1954, The hemolytic effect of primaquine. IV. the relationship of cell age to hemolysis, The Journal of Laboratory and Clinical Medicine, 44, 439
  4. Beutler, 1954, The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes, The Journal of Laboratory and Clinical Medicine, 44, 177
  5. Beutler, 1955, The hemolytic effect of primaquine. VII. biochemical studies of drug-sensitive erythrocytes, The Journal of Laboratory and Clinical Medicine, 45, 286
  6. Beutler, 1959, The hemolytic effect of primaquine and related compounds: a review, Blood, 14, 103, 10.1182/blood.V14.2.103.103 · DOI · Paper page
  7. Beutler, 1962, The normal human female as a mosaic of x-chromosome activity: studies using the gene for g-6-pd-deficiency as a marker, PNAS, 48, 9, 10.1073/pnas.48.1.9 · DOI · Paper page
  8. Beutler, 2007, Glucose-6-phosphate dehydrogenase deficiency: a historical perspective, Blood, 111, 16, 10.1182/blood-2007-04-077412 · DOI · Paper page
  9. Brito, 2016, Validation of the rapid test carestart(tm) G6PD among malaria vivax-infected subjects in the brazilian amazon, Revista da Sociedade Brasileira de Medicina Tropical, 49, 446, 10.1590/0037-8682-0134-2016 · doi:10.1590/0037-8682-0134-2016
  10. Cappellini, 2008, Glucose-6-phosphate dehydrogenase deficiency, The Lancet, 371, 64, 10.1016/S0140-6736(08)60073-2 · DOI · Paper page
  11. Charoenlarp, 1972, The haemolytic effect of a single dose of 45 mg of primaquine in G-6-PD deficient thais, Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 55, 631
  12. Chu, 2017, Haemolysis in G6PD heterozygous females treated with primaquine for plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens, PLoS Medicine, 14, e1002224, 10.1371/journal.pmed.1002224 · DOI · Paper page
  13. Dern, 1954, The hemolytic effect of primaquine. II. the natural course of the hemolytic anemia and the mechanism of its self-limited character, The Journal of Laboratory and Clinical Medicine, 44, 171
  14. Everett, 1977, Hemoglobin E and glucose-6-phosphate deficiency in the khmer air force (Cambodia), The American journal of tropical medicine and hygiene, 26, 597, 10.4269/ajtmh.1977.26.597 · doi:10.4269/ajtmh.1977.26.597
  15. Gething, 2012, A long neglected world malaria map: plasmodium vivax endemicity in 2010, PLoS Neglected Tropical Diseases, 6, e1814, 10.1371/journal.pntd.0001814 · DOI · Paper page
  16. Hillman, 1969, Characteristics of marrow production and reticulocyte maturation in normal man in response to anemia, Journal of Clinical Investigation, 48, 443, 10.1172/JCI106001 · DOI
  17. Howes, 2013, G6PD deficiency: global distribution, genetic variants and primaquine therapy, Advances in Parasitology, 81, 133, 10.1016/B978-0-12-407826-0.00004-7 · DOI · Paper page
  18. John, 2012, Primaquine radical cure of plasmodium vivax: a critical review of the literature, Malaria Journal, 11, 1, 10.1186/1475-2875-11-280 · DOI · Paper page
  19. Kheng, 2015, Tolerability and safety of weekly primaquine against relapse of plasmodium vivax in cambodians with glucose-6-phosphate dehydrogenase deficiency, BMC Medicine, 13, 203, 10.1186/s12916-015-0441-1 · DOI
  20. Lee, 2008, The relationship between the haemoglobin concentration and the haematocrit in plasmodium falciparum malaria, Malaria Journal, 7, 149, 10.1186/1475-2875-7-149 · DOI
  21. Leslie, 2008, A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan, PLoS One, 3, e2861, 10.1371/journal.pone.0002861 · DOI
  22. Oo, 2016, Validation of G6PD Point-of-Care tests among healthy volunteers in Yangon, Myanmar, PLoS One, 11, e0152304, 10.1371/journal.pone.0152304 · DOI · Paper page
  23. Pannacciulli, 1965, The course of experimentally induced hemolytic anemia in A primaquine-sensitive caucasian. a case study, Blood, 25, 92, 10.1182/blood.V25.1.92.92 · DOI · Paper page
  24. Price, 2007, Vivax malaria: neglected and not benign, The American Journal of Tropical Medicine and Hygiene, 77, 79, 10.4269/ajtmh.2007.77.79 · DOI · Paper page
  25. Recht, 2014, Safety of 8-aminoquinoline antimalarial medicines
  26. Salvidio, 1967, Nature of hemolytic crises and the fate of G6PD deficient, drug-damaged erythrocytes in Sardinians, New England Journal of Medicine, 276, 1339, 10.1056/NEJM196706152762402 · doi:10.1056/nejm196706152762402
  27. Satyagraha, 2016, Assessment of Point-of-Care diagnostics for G6PD deficiency in malaria endemic rural eastern indonesia, PLOS Neglected Tropical Diseases, 10, e0004457, 10.1371/journal.pntd.0004457 · DOI · Paper page
  28. Savill, 2009, Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia, PLoS Computational Biology, 5, e1000416, 10.1371/journal.pcbi.1000416 · DOI
  29. White, 2011, Determinants of relapse periodicity in plasmodium vivax malaria, Malaria Journal, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page

Cited by

See all 59

Metadata

Authors
Watson, J., Taylor, W. R., Menard, D., Kheng, S., & White, N. J.
Affiliations
  • Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
  • Unité d'Epidémiologie Moléculaire du Paludisme, Institut Pasteur du Cambodge, Phnom Penh, Cambodia
  • National Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia
Venue
eLife
Published
2017-02-04
Volume
6
ISSN
2050-084X
Cited by
59
References
0
Language
en
Funders
Wellcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modelling primaquine-induced haemolysis in G6PD deficiency. https://app.cochat.ai/papers/10.7554/elife.23061
The paper
Watson, J., Taylor, W. R., Menard, D., Kheng, S., & White, N. J. (2017). Modelling primaquine-induced haemolysis in G6PD deficiency. eLife. https://doi.org/10.7554/elife.23061

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.